# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-165183
Filing Date
2026-04-21
Accepted
2026-04-21 08:18:11
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | 2025_ars_for_2026_proxy.pdf | ARS | 2389266
| Complete submission text file | 0001193125-26-165183.txt |  | 3292093

Mailing Address BAARERSTRASSE 14 ZUG Switzerland
Business Address BAARERSTRASSE 14 ZUG Switzerland 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37923 | Film No.: 26876801
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)